SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivo Bio Tech informs about change in management

30 Jun 2025 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Vivo Bio Tech has informed that Kunda Kalpana has completed her term of 5 years as Independent Director of the Company from the end of the day on June 29, 2025. The Board of Directors and the Management of the Company expressed deep appreciation and gratitude for her extensive contribution and stewardship. The details with respect to the cessation of Director of Company as per the SEBI Listing Regulations read with the SEBI Master circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11 November 2024, is enclosed as Annexure - A. 

The above information is a part of company’s filings submitted to BSE.

Vivo Bio Tech Share Price

28.78 0.77 (2.75%)
22-Apr-2026 12:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1663.20
Dr. Reddys Lab 1225.70
Cipla 1236.25
Zydus Lifesciences 928.85
Lupin 2314.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×